Study author Dr Dhruv Kazi said that the availability of cheap, effective generic versions of statins and ezetimibe makes the price of Praluent (alirocumab) harder to swallow. "Your additional ...
The companies followed the data with an announcement to cut the price of Praluent (alirocumab) for the high-risk patients who need it the most – a one-two combination aimed at knocking down ...